Restricted accessResearch articleFirst published online 2014-02
LPS-Stimulated Inflammatory Environment Inhibits BMP-2-Induced Osteoblastic Differentiation Through Crosstalk Between TLR4/MyD88/NF-κB and BMP/Smad Signaling
Bone morphogenetic protein-2 (BMP-2) is a novel differentiation factor that is capable of inducing osteoblast differentiation and bone formation, making it an attractive option in treatment of bone defects, fractures, and spine fusions. Inflammation, which was a common situation during bone healing, is recognized to inhibit osteogenic differentiation and bone formation. However, the effect of inflammation on BMP-2-induced osteoblastic differentiation remains ambiguous. In this study, we showed that an inflammatory environment triggered by lipopolysaccharide (LPS) in vitro would suppress BMP-2-induced osteogenic differentiation of bone marrow mesenchymal stem cells, which represented by decreased alkaline phosphatase (ALPase) activity and down-regulated osteogenic genes. In addition, LPS activated nuclear factor-κB (NF-κB) via a TLR4/MyD88-dependent manner and inhibited BMP-2-induced phosphorylation and nuclear translocation of Smad1/5/8. The blocking of NF-κB signaling by pretreatment with specific inhibitors such as BAY-11-7082, TPCK and PDTC, or by transfection with plasmids encoding p65 siRNA or IκBα siRNA could significantly reverse the inhibitory effect of LPS on BMP-2-induced BMP/Smad signaling and osteogenic differentiation. By contrast, even without stimulation of LPS, overexpression of p65 gene showed obvious inhibitory effects on BMP-2-induced BMP/Smad signaling and ALPase activity. These data indicate that the LPS-mediated inflammatory environment inhibits BMP-2-induced osteogenic differentiation, and that the crosstalk between TLR4/MyD88/NF-κB and BMP/Smad signaling negatively modulates the osteoinductive capacity of BMP-2.
Get full access to this article
View all access options for this article.
References
1.
RosenV. (2009). BMP2 signaling in bone development and repair. Cytokine Growth Factor Rev, 20:475–480.
2.
McKayWF, PeckhamSM and BaduraJM. (2007). A comprehensive clinical review of recombinant human bone morphogenetic protein-2 (INFUSE Bone Graft). Int Orthop, 31:729–734.
3.
BenglisD, WangMY and LeviAD. (2008). A comprehensive review of the safety profile of bone morphogenetic protein in spine surgery. Neurosurgery, 62:ONS423–431; discussion ONS431.
4.
Lissenberg-ThunnissenSN, de GorterDJ, SierCF and SchipperIB. (2011). Use and efficacy of bone morphogenetic proteins in fracture healing. Int Orthop, 35:1271–1280.
5.
LeeKB, TaghaviCE, SongKJ, SintuuC, YooJH, KeorochanaG, TzengST, FeiZ, LiaoJC and WangJC. (2011). Inflammatory characteristics of rhBMP-2 in vitro and in an in vivo rodent model. Spine (Phila Pa 1976), 36:E149–E154.
6.
LeeKB, TaghaviCE, MurraySS, SongKJ, KeorochanaG and WangJC. (2012). BMP induced inflammation: a comparison of rhBMP-7 and rhBMP-2. J Orthop Res, 30:1985–1994.
7.
TanY, MontgomerySR, AghdasiBG, InoueH, KanerT, TianH, TerrellR, ZhangX, WangJC and DaubsMD. (2013). The effect of corticosteroid administration on soft-tissue inflammation associated with rhBMP-2 use in a rodent model of inflammation. Spine (Phila Pa 1976), 38:806–813.
8.
TakedaK and AkiraS. (2005). Toll-like receptors in innate immunity. Int Immunol, 17:1–14.
9.
WuG, LiuY, IizukaT and HunzikerEB. (2010). The effect of a slow mode of BMP-2 delivery on the inflammatory response provoked by bone-defect-filling polymeric scaffolds. Biomaterials, 31:7485–7493.
10.
LeeKB, MurraySS, TaghaviCE, SongKJ, BrochmannEJ, JohnsonJS, KeorochanaG, LiaoJC and WangJC. (2011). Bone morphogenetic protein-binding peptide reduces the inflammatory response to recombinant human bone morphogenetic protein-2 and recombinant human bone morphogenetic protein-7 in a rodent model of soft-tissue inflammation. Spine J, 11:568–576.
11.
RatanavarapornJ, FuruyaH and TabataY. (2012). Local suppression of pro-inflammatory cytokines and the effects in BMP-2-induced bone regeneration. Biomaterials, 33:304–316.
12.
MountziarisPM and MikosAG. (2008). Modulation of the inflammatory response for enhanced bone tissue regeneration. Tissue Eng Part B Rev, 14:179–186.
13.
ThomasMV and PuleoDA. (2011). Infection, inflammation, and bone regeneration: a paradoxical relationship. J Dent Res, 90:1052–1061.
14.
RundleCH, WangH, YuH, ChadwickRB, DavisEI, WergedalJE, LauKH, MohanS, RyabyJT and BaylinkDJ. (2006). Microarray analysis of gene expression during the inflammation and endochondral bone formation stages of rat femur fracture repair. Bone, 38:521–529.
15.
BischoffDS, ZhuJH, MakhijaniNS, KumarA and YamaguchiDT. (2008). Angiogenic CXC chemokine expression during differentiation of human mesenchymal stem cells towards the osteoblastic lineage. J Cell Biochem, 103:812–824.
16.
SchettG. (2011). Effects of inflammatory and anti-inflammatory cytokines on the bone. Eur J Clin Invest, 41:1361–1366.
17.
TomomatsuN, AokiK, AllesN, SoysaNS, HussainA, NakachiH, KitaS, ShimokawaH, OhyaK and AmagasaT. (2009). LPS-induced inhibition of osteogenesis is TNF-alpha dependent in a murine tooth extraction model. J Bone Miner Res, 24:1770–1781.
18.
ZhaoL, HuangJ, ZhangH, WangY, MatesicLE, TakahataM, AwadH, ChenD and XingL. (2011). Tumor necrosis factor inhibits mesenchymal stem cell differentiation into osteoblasts via the ubiquitin E3 ligase Wwp1. Stem Cells, 29:1601–1610.
19.
PeruzziB, CapparielloA, DelFA, RucciN, De BenedettiF and TetiA. (2012). c-Src and IL-6 inhibit osteoblast differentiation and integrate IGFBP5 signalling. Nat Commun, 3:630
20.
LaceyDC, SimmonsPJ, GravesSE and HamiltonJA. (2009). Proinflammatory cytokines inhibit osteogenic differentiation from stem cells: implications for bone repair during inflammation. Osteoarthritis Cartilage, 17:735–742.
21.
KangJY and LeeJO. (2011). Structural biology of the Toll-like receptor family. Annu Rev Biochem, 80:917–941.
22.
LeeMS and KimYJ. (2007). Signaling pathways downstream of pattern-recognition receptors and their cross talk. Annu Rev Biochem, 76:447–480.
23.
LuYC, YehWC and OhashiPS. (2008). LPS/TLR4 signal transduction pathway. Cytokine, 42:145–151.
24.
BrownJ, WangH, HajishengallisGN and MartinM. (2011). TLR-signaling networks: an integration of adaptor molecules, kinases, and cross-talk. J Dent Res, 90:417–427.
25.
AkiraS, UematsuS and TakeuchiO. (2006). Pathogen recognition and innate immunity. Cell, 124:783–801.
26.
Shaik-DasthagirisahebYB, HuangN, BaerMT and GibsonFC3rd. (2013). Role of MyD88-dependent and MyD88-independent signaling in Porphyromonas gingivalis-elicited macrophage foam cell formation. Mol Oral Microbiol, 28:28–39.
27.
WarnerN and NunezG. (2013). MyD88: a critical adaptor protein in innate immunity signal transduction. J Immunol, 190:3–4.
28.
GhoshS and HaydenMS. (2008). New regulators of NF-kappaB in inflammation. Nat Rev Immunol, 8:837–848.
29.
KarinM. (2008). The IkappaB kinase - a bridge between inflammation and cancer. Cell Res, 18:334–342.
30.
NovackDV. (2011). Role of NF-kappaB in the skeleton. Cell Res, 21:169–182.
31.
ChenCT, ShihYR, KuoTK, LeeOK and WeiYH. (2008). Coordinated changes of mitochondrial biogenesis and antioxidant enzymes during osteogenic differentiation of human mesenchymal stem cells. Stem Cells, 26:960–968.
32.
YamazakiM, FukushimaH, ShinM, KatagiriT, DoiT, TakahashiT and JimiE. (2009). Tumor necrosis factor alpha represses bone morphogenetic protein (BMP) signaling by interfering with the DNA binding of Smads through the activation of NF-kappaB. J Biol Chem, 284:35987–35995.
33.
EliseevRA, SchwarzEM, ZuscikMJ, O'KeefeRJ, DrissiH and RosierRN. (2006). Smad7 mediates inhibition of Saos2 osteosarcoma cell differentiation by NFkappaB. Exp Cell Res, 312:40–50.
34.
ChangJ, WangZ, TangE, FanZ, McCauleyL, FranceschiR, GuanK, KrebsbachPH and WangCY. (2009). Inhibition of osteoblastic bone formation by nuclear factor-kappaB. Nat Med, 15:682–689.
35.
ten DijkeP. (2006). Bone morphogenetic protein signal transduction in bone. Curr Med Res Opin, 22Suppl 1:S7–S11.
36.
HyzySL, Olivares-NavarreteR, SchwartzZ and BoyanBD. (2012). BMP2 induces osteoblast apoptosis in a maturation state and noggin-dependent manner. J Cell Biochem, 113:3236–3245.
37.
OeckinghausA, HaydenMS and GhoshS. (2011). Crosstalk in NF-kappaB signaling pathways. Nat Immunol, 12:695–708.
38.
CayrolR, WosikK, BerardJL, Dodelet-DevillersA, IferganI, KebirH, HaqqaniAS, KreymborgK, KrugSet al., (2008). Activated leukocyte cell adhesion molecule promotes leukocyte trafficking into the central nervous system. Nat Immunol, 9:137–145.
39.
ZhangD, ChenL, LiS, GuZ and YanJ. (2008). Lipopolysaccharide (LPS) of Porphyromonas gingivalis induces IL-1beta, TNF-alpha and IL-6 production by THP-1 cells in a way different from that of Escherichia coli LPS. Innate Immun, 14:99–107.
40.
MontzkaK, FuhrmannT, Muller-EhmsenJ, WoltjeM and BrookGA. (2010). Growth factor and cytokine expression of human mesenchymal stromal cells is not altered in an in vitro model of tissue damage. Cytotherapy, 12:870–880.
41.
LangeJ, SapozhnikovaA, LuC, HuD, LiX, MiclauT3rd and MarcucioRS. (2010). Action of IL-1beta during fracture healing. J Orthop Res, 28:778–784.
42.
MukaiT, OtsukaF, OtaniH, YamashitaM, TakasugiK, InagakiK, YamamuraM and MakinoH. (2007). TNF-alpha inhibits BMP-induced osteoblast differentiation through activating SAPK/JNK signaling. Biochem Biophys Res Commun, 356:1004–1010.
43.
YamashitaM, OtsukaF, MukaiT, OtaniH, InagakiK, MiyoshiT, GotoJ, YamamuraM and MakinoH. (2008). Simvastatin antagonizes tumor necrosis factor-alpha inhibition of bone morphogenetic proteins-2-induced osteoblast differentiation by regulating Smad signaling and Ras/Rho-mitogen-activated protein kinase pathway. J Endocrinol, 196:601–613.
44.
MatsumotoY, OtsukaF, TakanoM, MukaiT, YamanakaR, TakedaM, MiyoshiT, InagakiK, SadaKE and MakinoH. (2010). Estrogen and glucocorticoid regulate osteoblast differentiation through the interaction of bone morphogenetic protein-2 and tumor necrosis factor-alpha in C2C12 cells. Mol Cell Endocrinol, 325:118–127.
45.
HessK, UshmorovA, FiedlerJ, BrennerRE and WirthT. (2009). TNFalpha promotes osteogenic differentiation of human mesenchymal stem cells by triggering the NF-kappaB signaling pathway. Bone, 45:367–376.
46.
FengX, FengG, XingJ, ShenB, LiL, TanW, XuY, LiuS, LiuHet al., (2013). TNF-alpha triggers osteogenic differentiation of human dental pulp stem cells via the NF-kappaB signaling pathway. Cell Biol Int. [Epub ahead of print];DOI: 10.1002/cbin.10141.
47.
SonomotoK, YamaokaK, OshitaK, FukuyoS, ZhangX, NakanoK, OkadaY and TanakaY. (2012). Interleukin-1beta induces differentiation of human mesenchymal stem cells into osteoblasts via the Wnt-5a/receptor tyrosine kinase-like orphan receptor 2 pathway. Arthritis Rheum, 64:3355–3363.
48.
LeGB, BlanchardF, BerthelotJM, HeymannD and MaugarsY. (2010). Role for interleukin-6 in structural joint damage and systemic bone loss in rheumatoid arthritis. Joint Bone Spine, 77:201–205.
49.
CalichVL, PinaA, FelonatoM, BernardinoS, CostaTA and LouresFV. (2008). Toll-like receptors and fungal infections: the role of TLR2, TLR4 and MyD88 in paracoccidioidomycosis. FEMS Immunol Med Microbiol, 53:1–7.
50.
HeW, QuT, YuQ, WangZ, WangH, ZhangJ and SmithAJ. (2012). Lipopolysaccharide enhances decorin expression through the Toll-like receptor 4, myeloid differentiating factor 88, nuclear factor-kappa B, and mitogen-activated protein kinase pathways in odontoblast cells. J Endod, 38:464–469.
51.
HeW, QuT, YuQ, WangZ, LvH, ZhangJ, ZhaoX and WangP. (2012). LPS induces IL-8 expression through TLR4, MyD88, NF-kappaB and MAPK pathways in human dental pulp stem cells. Int Endod J, 46:128–136.
52.
CarreroR, CerradaI, LledoE, DopazoJ, Garcia-GarciaF, RubioMP, TriguerosC, DorronsoroA, Ruiz-SauriA, MonteroJA and SepulvedaP. (2012). IL1beta Induces Mesenchymal Stem Cells Migration and Leucocyte Chemotaxis Through NF-kappaB. Stem Cell Rev, 8:905–916.
53.
TangY, XieH, ChenJ, GengL, ChenH, LiX, HouY, LuL, ShiS, ZengX and SunL. (2013). Activated NF-κB in bone marrow mesenchymal stem cells from systemic lupus erythematosus patients inhibits osteogenic differentiation through downregulating Smad signaling. Stem Cells Dev, 22:668–678.
54.
ZhenH, WangJ, XueL, RuiJ, LiuX and ChenY. (2012). LPS-pretreated bone marrow stem cells as potential treatment for myocardial infraction. Front Biosci, 17:1294–1303.
55.
LiLC, VargheseZ, MoorheadJF, LeeCT, ChenJB and RuanXZ. (2013). Cross-talk between TLR4-MyD88-NF-kappaB and SCAP-SREBP2 pathways mediates macrophage foam cell formation. Am J Physiol Heart Circ Physiol, 304:H874–H884.
56.
YuS, ChoHH, JooHJ, BaeYC and JungJS. (2008). Role of MyD88 in TLR agonist-induced functional alterations of human adipose tissue-derived mesenchymal stem cells. Mol Cell Biochem, 317:143–150.
57.
BagchiAK, SharmaA, DhingraS, LehenbauerLAR, Al-ShudiefatAA and SingalPK. (2013). Interleukin-10 activates Toll-like receptor 4 and requires MyD88 for cardiomyocyte survival. Cytokine, 61:304–314.
58.
ChenG, DengC and LiYP. (2012). TGF-beta and BMP signaling in osteoblast differentiation and bone formation. Int J Biol Sci, 8:272–288.
59.
LiY, LiA, StraitK, ZhangH, NanesMS and WeitzmannMN. (2007). Endogenous TNFalpha lowers maximum peak bone mass and inhibits osteoblastic Smad activation through NF-kappaB. J Bone Miner Res, 22:646–655.
60.
LouJ, TuY, LiS and ManskePR. (2000). Involvement of ERK in BMP-2 induced osteoblastic differentiation of mesenchymal progenitor cell line C3H10T1/2. Biochem Biophys Res Commun, 268:757–762.
61.
LiW, YuB, LiM, SunD, HuY, ZhaoM, CuiCB and HouS. (2010). NEMO-binding domain peptide promotes osteoblast differentiation impaired by tumor necrosis factor alpha. Biochem Biophys Res Commun, 391:1228–1233.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
